We have previously reported that the proteasome subunits, PSMD1 and PSMD3, are upregulated during progression of CML from the indolent chronic phase to the aggressive blast phase of the disease [21]. This evidence concerns the gene PSMD3 and chronic myelogenous leukemia, BCR-ABL1 positive.